MMedication Read More Novo Nordisk sues Hims & Hers over compounded obesity drugsFebruary 11, 2026 Novo Nordisk on Monday said it is suing online telehealth provider Hims & Hers for mass marketing cheaper,…
EEntertainment Read More Stocks making the biggest moves midday: AMZN, CNC, RBLXFebruary 6, 2026 Check out the companies making headlines in midday trading. Centene — Shares of the health insurance provider slid…
MMedication Read More Hims & Hers falls 8% after Novo’s legal threat. Here’s the latestFebruary 6, 2026 Rafael Henrique | SOPA Images | AP The stock of Hims & Hers dropped in premarket trading early…
MMedication Read More Hims & Hers announces Wegovy pill copy; Novo Nordisk vows legal actionFebruary 5, 2026 The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark,…
HHealthcare Read More Novo Nordisk has published its annual report for 2025February 5, 2026 Bagsværd, Denmark, 4 February 2026 – Today, Novo Nordisk A/S has issued its 2025 annual report. The report is…
MMusic Read More We’re raising our price target on Eli Lilly as the GLP-1 leader deliversFebruary 4, 2026 Eli Lilly ‘s fourth-quarter results blew past Wall Street estimates on Wednesday, as key GLP-1 drugs, Mounjaro for…
BBusiness Read More Stock market today: Live updatesFebruary 4, 2026 Traders work on the floor of the New York Stock Exchange (NYSE) in New York, US, on Wednesday,…
HHealthcare Read More Eli Lilly (LLY) earnings Q4 2025February 4, 2026 Eli Lilly on Wednesday posted fourth-quarter earnings and revenue and 2026 guidance that blew past estimates, as demand…
EEntertainment Read More Why the market is worried about Lilly’s earnings but cautiously optimistic on housingFebruary 3, 2026 Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
HHealthcare Read More Pfizer’s monthly obesity injection drove shows promise in trialFebruary 3, 2026 Smith Collection | Archive Photos | Getty Images Pfizer on Thursday said its experimental obesity drug, which it…
HHealthcare Read More Eli Lilly CEO David Ricks talks Medicare coverage of obesity pillsJanuary 30, 2026 Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major…
HHealthcare Read More Eli Lilly plans $3.5 billion Pennsylvania plant for obesity drugsJanuary 30, 2026 Eli Lilly Chair and CEO Dave Ricks speaks during a press conference in Houston, Sept. 23, 2025. Antranik…